Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data
- Author
- VCELAR, Brigitta1 ; STIEGLER, Gabriela1 ; KATINGER, Hermann1 6 ; WOLF, Hermann M2 ; MUNTEAN, Wolfgang3 ; LESCHNIK, Bettina3 ; MEHANDRU, Saurabh4 ; MARKOWITZ, Martin4 ; ARMBRUSTER, Christine5 ; KUNERT, Renate6 ; EIBL, Martha M2
[1] Polymun Scientific, University of Natural Resources and Applied Life Sciences, Vienna, United States
[2] Immunology Outpatient Clinic, University of Natural Resources and Applied Life Sciences, Vienna, United States
[3] Department of Pediatrics, Medical University of Graz, Austria
[4] Aaron Diamond AIDS Research Center, The Rockefeller University, New York, United States
[5] Otto Wagner Hospital, University of Natural Resources and Applied Life Sciences, Vienna, United States
[6] Institute of Applied Microbiology, University of Natural Resources and Applied Life Sciences, Vienna, United States - Source
AIDS (London). 2007, Vol 21, Num 16, pp 2161-2170, 10 p ; ref : 37 ref
- ISSN
- 0269-9370
- Scientific domain
- Immunology, immunopathology, allergology; Microbiology, infectious diseases
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- HIV-1 infection autoreactivity cardiolipin clinical safety neutralizing antibodies
- Keyword (fr)
- Autoimmunité Diphosphatidylglycérol Embolie Homme Hémostatique Immunothérapie Incidence Neutralisation SIDA Spécificité Symptomatologie Thromboembolie Thromboplastine Thrombose Traitement Virus HIV1 Appareil circulatoire pathologie Epidémiologie Immunodéficit Immunopathologie Infection Lentivirus Retroviridae Vaisseau sanguin pathologie Virose Virus immunodéficience humaine Virus
- Keyword (en)
- Autoimmunity Diphosphatidylglycerol Embolism Human Hemostatic Immunotherapy Incidence Neutralization AIDS Specificity Symptomatology Thromboembolism Thromboplastin Thrombosis Treatment HIV-1 virus Cardiovascular disease Epidemiology Immune deficiency Immunopathology Infection Lentivirus Retroviridae Vascular disease Viral disease Human immunodeficiency virus Virus
- Keyword (es)
- Autoinmunidad Difosfatidilglicerol Embolia Hombre Hemostático Inmunoterapia Incidencia Neutralización SIDA Especificidad Sintomatología Tromboembolia Tromboplastina Trombosis Tratamiento HIV-1 virus Aparato circulatorio patología Epidemiología Inmunodeficiencia Inmunopatología Infección Lentivirus Retroviridae Vaso sanguíneo patología Virosis Human immunodeficiency virus Virus
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B06 Immunopathology / 002B06D Immunodeficiencies. Immunoglobulinopathies / 002B06D01 Immunodeficiencies
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B03 Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous
- Discipline
- Cardiology. Circulatory system Immunopathology Infectious pathology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 19241701
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1097/QAD.0b013e328285da15 
https://dx.doi.org/10.1097/QAD.0b013e328285da15
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e328285da15\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data\";s:9:\"\u0000*\u0000jtitle\";s:13:\"AIDS (London)\";s:9:\"\u0000*\u0000stitle\";s:12:\"AIDS (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"2161\";s:8:\"\u0000*\u0000epage\";s:4:\"2170\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-9370\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"VCELAR\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Brigitta\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:18:\"STIEGLER, Gabriela\";i:1;s:17:\"KATINGER, Hermann\";i:2;s:15:\"WOLF, Hermann M\";i:3;s:17:\"MUNTEAN, Wolfgang\";i:4;s:17:\"LESCHNIK, Bettina\";i:5;s:17:\"MEHANDRU, Saurabh\";i:6;s:17:\"MARKOWITZ, Martin\";i:7;s:21:\"ARMBRUSTER, Christine\";i:8;s:14:\"KUNERT, Renate\";i:9;s:14:\"EIBL, Martha M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e328285da15\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data\";s:9:\"\u0000*\u0000jtitle\";s:13:\"AIDS (London)\";s:9:\"\u0000*\u0000stitle\";s:12:\"AIDS (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"2161\";s:8:\"\u0000*\u0000epage\";s:4:\"2170\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-9370\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"VCELAR\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Brigitta\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:18:\"STIEGLER, Gabriela\";i:1;s:17:\"KATINGER, Hermann\";i:2;s:15:\"WOLF, Hermann M\";i:3;s:17:\"MUNTEAN, Wolfgang\";i:4;s:17:\"LESCHNIK, Bettina\";i:5;s:17:\"MEHANDRU, Saurabh\";i:6;s:17:\"MARKOWITZ, Martin\";i:7;s:21:\"ARMBRUSTER, Christine\";i:8;s:14:\"KUNERT, Renate\";i:9;s:14:\"EIBL, Martha M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e328285da15\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e328285da15\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data\";s:9:\"\u0000*\u0000jtitle\";s:13:\"AIDS (London)\";s:9:\"\u0000*\u0000stitle\";s:12:\"AIDS (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"2161\";s:8:\"\u0000*\u0000epage\";s:4:\"2170\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-9370\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"VCELAR\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Brigitta\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:18:\"STIEGLER, Gabriela\";i:1;s:17:\"KATINGER, Hermann\";i:2;s:15:\"WOLF, Hermann M\";i:3;s:17:\"MUNTEAN, Wolfgang\";i:4;s:17:\"LESCHNIK, Bettina\";i:5;s:17:\"MEHANDRU, Saurabh\";i:6;s:17:\"MARKOWITZ, Martin\";i:7;s:21:\"ARMBRUSTER, Christine\";i:8;s:14:\"KUNERT, Renate\";i:9;s:14:\"EIBL, Martha M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e328285da15\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data\";s:9:\"\u0000*\u0000jtitle\";s:13:\"AIDS (London)\";s:9:\"\u0000*\u0000stitle\";s:12:\"AIDS (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"2161\";s:8:\"\u0000*\u0000epage\";s:4:\"2170\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-9370\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"VCELAR\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Brigitta\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:18:\"STIEGLER, Gabriela\";i:1;s:17:\"KATINGER, Hermann\";i:2;s:15:\"WOLF, Hermann M\";i:3;s:17:\"MUNTEAN, Wolfgang\";i:4;s:17:\"LESCHNIK, Bettina\";i:5;s:17:\"MEHANDRU, Saurabh\";i:6;s:17:\"MARKOWITZ, Martin\";i:7;s:21:\"ARMBRUSTER, Christine\";i:8;s:14:\"KUNERT, Renate\";i:9;s:14:\"EIBL, Martha M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:28:\"10.1097\/QAD.0b013e328285da15\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data\";s:9:\"\u0000*\u0000jtitle\";s:13:\"AIDS (London)\";s:9:\"\u0000*\u0000stitle\";s:12:\"AIDS (Lond.)\";s:7:\"\u0000*\u0000date\";s:4:\"2007\";s:9:\"\u0000*\u0000volume\";s:2:\"21\";s:8:\"\u0000*\u0000issue\";s:2:\"16\";s:8:\"\u0000*\u0000spage\";s:4:\"2161\";s:8:\"\u0000*\u0000epage\";s:4:\"2170\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0269-9370\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"VCELAR\";s:10:\"\u0000*\u0000aufirst\";s:8:\"Brigitta\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:18:\"STIEGLER, Gabriela\";i:1;s:17:\"KATINGER, Hermann\";i:2;s:15:\"WOLF, Hermann M\";i:3;s:17:\"MUNTEAN, Wolfgang\";i:4;s:17:\"LESCHNIK, Bettina\";i:5;s:17:\"MEHANDRU, Saurabh\";i:6;s:17:\"MARKOWITZ, Martin\";i:7;s:21:\"ARMBRUSTER, Christine\";i:8;s:14:\"KUNERT, Renate\";i:9;s:14:\"EIBL, Martha M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Reassessment of autoreactivity of the broadly neutralizing HIV antibodies 4E10 and 2F5 and retrospective analysis of clinical safety data\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"10\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
